Daniel Sanghoon Shin

Author

University of California, Los Angeles ORCID

Also Known As

Abhijat Kitchlu, Daniel S. Shin, Daniel Sanghoon Shin, Daniel Shin, Kimberly A. Sullivan, Shin, Daniel Sanghoon, Sunil Rangarajan

178

Publications

9.9K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Albert Einstein College of Medicine VA Greater Los Angeles Healthcare System The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center

About

Daniel Sanghoon Shin is an author at University of California, Los Angeles specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	651
2	Natural Sciences	7	7	232
3	Biochemistry	7	7	232
4	Cell Biology	3	3	432
5	Biomolecular Engineering	1	1	42

Daniel Sanghoon Shin

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma Jesse M. Zaretsky, Ángel García-Díaz, Daniel Sanghoon Shin, New England Journal of Medicine	2016	3.1K
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression Ángel García-Díaz, Daniel Sanghoon Shin, Blanca Homet Moreno, Cell Reports	2017	1.8K
Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations Daniel Sanghoon Shin, Jesse M. Zaretsky, Helena Escuin-Ordinas, Cancer Discovery	2016	1.2K
Genetic Mechanisms of Immune Evasion in Colorectal Cancer Catherine S. Grasso, Marios Giannakis, Daniel K. Wells, Cancer Discovery	2018	534
PD-1 Blockade Expands Intratumoral Memory T Cells Antoni Ribas, Daniel Sanghoon Shin, Jesse M. Zaretsky, Cancer Immunology Research	2016	398
Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study Frank B. Cortazar, Zoé A. Kibbelaar, Ilya Glezerman, Journal of the American Society of Nephrology	2020	370
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko, Cancer Cell Tumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTumor Immunity	2020	361
Acute kidney injury in patients treated with immune checkpoint inhibitors Shruti Gupta, Samuel Short, Meghan E. Sise, Journal for ImmunoTherapy of Cancer	2021	213
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Science Translational Medicine	2020	123
Phosphatase-Resistant Gap Junctions Inhibit Pathological Remodeling and Prevent Arrhythmias Benjamin Remo, Jiaxiang Qu, Frank Volpicelli, Circulation Research	2011	122

Page 1